CN105092754A - Method for determining sulfonate genotoxic impurity by using HPLC - Google Patents

Method for determining sulfonate genotoxic impurity by using HPLC Download PDF

Info

Publication number
CN105092754A
CN105092754A CN201410215531.2A CN201410215531A CN105092754A CN 105092754 A CN105092754 A CN 105092754A CN 201410215531 A CN201410215531 A CN 201410215531A CN 105092754 A CN105092754 A CN 105092754A
Authority
CN
China
Prior art keywords
damping fluid
organic phase
volume ratio
ratio
during
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410215531.2A
Other languages
Chinese (zh)
Other versions
CN105092754B (en
Inventor
严洁
李轩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Hankang Pharmaceutical Biotechnology Co Ltd
Original Assignee
Tianjin Hankang Pharmaceutical Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Hankang Pharmaceutical Biotechnology Co Ltd filed Critical Tianjin Hankang Pharmaceutical Biotechnology Co Ltd
Priority to CN201410215531.2A priority Critical patent/CN105092754B/en
Publication of CN105092754A publication Critical patent/CN105092754A/en
Application granted granted Critical
Publication of CN105092754B publication Critical patent/CN105092754B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a method for determining sulfonate genotoxic impurity (or suspected genotoxicity) by using HPLC. According to the invention, octadecylsilane chemically bonded silica is taken as a chromatographic column of a stationary phase, a mixed solvent of an organic phase and a buffer is performed with gradient elution to be taken as a mobile phase for direct detection. The detection method has the advantages of high sensitivity, strong specialization, high precision, strong accuracy and convenient operation; and the method has wide applicability and can effectively control the quality of the bulk drugs.

Description

A kind of method utilizing HPLC to measure sulfonic acid esters genotoxicity impurity
Technical field
The invention belongs to Pharmaceutical Analysis field, particularly, relate to one and utilize HPLC(high performance liquid chromatography) measure the method for sulfonic acid esters genotoxicity impurity.
Background technology
In pharmaceutical synthesis, methane-sulforic acid, the sulfonic acid substances such as benzene methanesulfonic acid generate alkyl sulfonic ester as methyl mesylate (MMS) with the lower alcohol of trace in synthetic reaction, ethyl methane sulfonate (EMS), normal-butyl methanesulfonates (NBMS), and aromatic yl sulphonate is as methyl benzene sulfonate (MBS), ethyl benzenesulfonat (EBS), p-toluenesulfonic acid ester (MP-TS), alkylated reaction can be there is in these materials with DNA, thus the inducement of cause cancer may be become, the existence of these latent gene toxic impurities causes the great attention of management organization, be defined in bulk drug the strict control carrying out related substance, European Union specify the limit of genotoxicity impurity be maximum day dosing be 1.5 μ g.
Exist in prior art and use HPLC method to measure sulfonic acid esters impurity, HPLC-UV method is the detection method relatively commonly used, as PR-HPLC method measures MBS, EBS in Amlodipine Besylate Tablet, the method adopts InretsilODS chromatographic column (150mm × 4.6mm, 5 μm), mobile phase is 1% triethylamine (Ph3.0)-acetonitrile, its degree of separation and peak shape are better, but detectability is lower, and when measured object concentration is lower, uv absorption may not be detected, thus impact measures.
At present, the sensitivity of China's conventional medicine determination method is only 10 to 60ppm, the analysis of quantitative and qualitative analysis cannot be carried out at all to genotoxicity impurity, by the continuous adjustment of synthetic route, intermediate and the starting material that may produce genotoxicity impurity can only be avoided.
Applicant finds, be the chromatographic column of Stationary liquid in order to octadecylsilane chemically bonded silica, the mixed solvent of organic phase and acetate buffer is as eluent gradient wash-out, sulfonic acid esters impurity can be detected, and highly sensitive (sensitivity can reach 0.75ppm), can effectively control bulk drug quality, solve genotoxicity cannot qualitative and quantitative analysis detect a difficult problem.
Summary of the invention
The invention provides a kind of method utilizing HPLC to measure sulfonic acid esters genotoxicity impurity, thus realize the control of trace sulfonic acid esters genotoxicity impurity in bulk drug.
Technical scheme of the present invention: a kind of method utilizing HPLC to measure sulfonic acid esters genotoxicity impurity is provided,
Selection octadecylsilane chemically bonded silica is Stationary liquid, using the mixed solvent of organic phase and damping fluid as eluent gradient wash-out.
Detecting step is as follows:
(1) set chromatographic condition: chromatographic column with octadecylsilane chemically bonded silica as Stationary liquid, using the mixed solvent of organic phase and damping fluid as eluent gradient wash-out, column temperature 20 DEG C ~ 30 DEG C, flow velocity is 0.8 ~ 1.2mL/min, and determined wavelength is 260nm ± 10nm;
(2) sample solution is prepared: adopt the mixed liquor of organic solvent or organic solvent and water that detected sample is mixed with sample solution;
(3) compartment analysis: by sample solution 10 μ L, injects high performance liquid chromatograph, completes the mensuration of sulfonic acid esters genotoxicity impurity.
Described organic phase is for being selected from acetonitrile.
Described damping fluid is that acetate rushes liquid.The concentration range of damping fluid is 0.005mol/L ~ 0.05mol/L, preferred 0.01mol/L.
The pH value of described damping fluid is 3.0 ~ 5.1.
Described mobile phase is the mixed solvent gradient elution of organic phase and damping fluid, and during gradient elution 0 ~ 5min, the ratio of damping fluid, organic phase is volume ratio 90%:10%; During 5 ~ 14min, damping fluid volume ratio is reduced to 80%, and organic phase volume ratio increases to 20%; 14 ~ 15min, buffer ratio is that volume ratio is reduced to 10%, and the ratio of organic phase is volume ratio when increasing to 90%:15 ~ 25min, and the ratio of damping fluid, organic phase is that volume ratio 10%:90% is constant; During 25 ~ 30min, damping fluid volume ratio increases to 90%, and organic phase volume ratio is reduced to 10%; During 30 ~ 35min, the ratio of damping fluid, organic phase is that volume ratio 90%:10% is constant.
Described testing conditions: column temperature 20 DEG C ~ 30 DEG C, preferably 25 DEG C; Flow velocity is 0.8 ~ 1.2mL/min, preferably
1.0mL/min。Determined wavelength is 260nm ± 10nm, preferred 260nm.
Detection method of the present invention, can realize according to following methods:
(1) get detected sample appropriate, dissolve with the mixed solvent of acetonitrile or it and water, be mixed with the sample solution of suitable concn.
(2) get sulfonic acid esters impurity appropriate, dissolve with the mixed solvent of acetonitrile or it and water, be mixed with the reference substance solution of suitable concn.
(3) arranging flow rate of mobile phase is 0.8 ~ 1.2mL/min, and the flow velocity of mobile phase is preferably 1.0mL/min; Detect
Wavelength 260nm; Chromatogram column temperature is 20 DEG C ~ 30 DEG C, is preferably 25 DEG C.
(4) get respectively (1), 2) sample solution and reference substance solution 10 μ L, inject high performance liquid chromatograph, complete the assay of sulfonic acid esters toxic impurities.
Technique effect of the present invention: by utilizing HPLC, carry out trace detection analysis to genotoxicity impurity in bulk drug (or doubtful genotoxicity) sulfonic acid esters toxic impurities, sensitivity can reach 0.75ppm.
Embodiment
Be described below in detail embodiments of the invention, it should be noted that embodiment described below is exemplary, only
For explaining the present invention, and limitation of the present invention can not be interpreted as.In addition, if do not clearly not stated, adopted in the following embodiments all reagent are, and market can be buied, or can according to text or the synthesis of known method, for the reaction conditions do not listed, be also that those skilled in the art easily obtain.
Embodiment 1
Instrument: Agilent1260 high performance liquid chromatograph, 1260 UV-detector
Chromatographic column: octadecylsilane chemically bonded silica is the chromatographic column (250 × 4.6mm, 5 μm) of filling agent;
The ammonium acetate buffer (pH5.1) of mobile phase A: 0.01mol/L
Mobile phase B: acetonitrile
Gradient elution sees the following form;
Flow velocity: 1.0mL/min
Determined wavelength: 260nm
Column temperature: 25 DEG C
Sampling volume: 10 μ L
Thinning agent: acetonitrile
Test procedure:
Need testing solution: take Amlodipine Besylate Tablet sample 1.0014g and put 10mL measuring bottle, dissolve with thinning agent and be diluted to scale, shaking up.
Reference substance solution: precision takes P-TOLUENE SULFO ACID 99's methyl esters reference substance 7.48mg and puts in 100mL measuring bottle, is diluted to scale by water-soluble solution, shakes up, as stock solution A.Precision measures 1.0mL stock solution A and puts in 100mL measuring bottle, is diluted to scale, shakes up with thinning agent, and as stock solution B, precision measures 1.0mL stock solution B and puts in 10mL measuring bottle, is diluted to scale, shakes up with thinning agent, in contrast product solution (0.75ppm).
Get reference substance, need testing solution respectively, under above-mentioned chromatographic condition, carry out efficient liquid phase chromatographic analysis, record chromatogram, the retention time methyl benzene sulfonate chromatographic peak that to be 6.282min chromatographic peak be in figure, adopts area normalization method to calculate impurity content.
Conclusion: the methyl benzene sulfonate in Amlodipine Besylate Tablet sample is less than 0.75ppm.
Embodiment 2
Instrument: Agilent1260 high performance liquid chromatograph, 1260 UV-detector
Chromatographic column: octadecylsilane chemically bonded silica is the chromatographic column (250 × 4.6mm, 5 μm) of filling agent;
The ammonium acetate buffer (pH3.0) of mobile phase A: 0.01mol/L
Mobile phase B: acetonitrile
Gradient elution sees the following form;
Flow velocity: 1.0mL/min
Determined wavelength: 250nm
Column temperature: 20 DEG C
Sampling volume: 10 μ L
Thinning agent: acetonitrile
Test procedure:
Need testing solution: take methane-sulforic acid T-3811 crude product 1.0014g and put 10mL measuring bottle, dissolve with thinning agent and be diluted to scale, shaking up.
Reference substance solution: precision takes methyl mesylate reference substance 37.42mg and puts in 100mL measuring bottle, molten with thinning agent
Separate and be diluted to scale, shaking up, as stock solution A.Precision measures 1.0mL stock solution A and puts in 100mL measuring bottle, is diluted to scale, shakes up with thinning agent, and as stock solution B, precision measures 1.0mL stock solution B and puts in 100mL measuring bottle, is diluted to scale, shakes up with thinning agent, in contrast product solution (3.75ppm).
Get reference substance, need testing solution respectively, under above-mentioned chromatographic condition, carry out efficient liquid phase chromatographic analysis, record chromatogram, in figure, retention time is 4.545min chromatographic peak is methyl mesylate chromatographic peak, adopts area normalization method to calculate impurity content.
Conclusion: this method is applicable to the content of the methyl mesylate detecting variable concentrations scope in methane-sulforic acid T-3811 sample.
Reference examples 1
Adopt the genotoxicity impurity of GC-FID method P-TOLUENE SULFO ACID 99 Amlodipine of the prior art to carry out detection to analyze, further checking the present invention adopt accuracy and the sensitivity of method.
The preparation of need testing solution: get Amlodipine Besylate Tablet appropriate, accurately weighed, first dissolve by little water, then by acetone diluted and constant volume makes 20mg/ml, as need testing solution; Get methyl benzene sulfonate reference substance appropriate, accurately weighed, also dilute with acetone solution and make 0.05mg/ml solution, product solution in contrast; Get above-mentioned need testing solution and reference substance solution headspace sampling in accordance with the law respectively, record chromatogram, with peak area external standard method result of calculation.
Chromatographic condition:
Injection port: shunting, temperature 250 DEG C;
Chromatographic column: polyglycol is that Stationary liquid or polarity are close;
Column temperature: temperature programme 150 DEG C keep 4 minutes then with 20 DEG C per minute be warmed up to 240 DEG C keep 5 minutes;
Column flow rate: 2.0ml/min;
Detecting device: flame ionization ditector (FID), temperature 280 DEG C;
Split sampling: split ratio 10:1;
Sample introduction pattern: headspace sampling;
Head-space sampler: furnace temperature 150 DEG C insulation 10 minutes, pin temperature 150 DEG C, sample size 1ml.
Define methyl benzene sulfonate according to the appearance time of reference substance solution and need testing solution to exist, and conform to the result that the present invention measures according to the content going out the methyl benzene sulfonate in peak area determination test sample of methyl benzene sulfonate.

Claims (9)

1. utilize HPLC to measure a method for sulfonic acid esters genotoxicity impurity, it is characterized in that:
(1) chromatographic condition: chromatographic column take octadecylsilane chemically bonded silica as Stationary liquid, using the mixed solvent of organic phase and damping fluid as eluent gradient wash-out, column temperature 20 DEG C ~ 30 DEG C, flow velocity is 0.8 ~ 1.2mL/min, and determined wavelength is 260nm ± 10nm;
(2) preparation of sample solution: adopt the mixed liquor of organic solvent or organic solvent and water that detected sample is mixed with sample solution;
(3) compartment analysis: by sample solution 10 μ L, injects high performance liquid chromatograph, completes the mensuration of sulfonic acid esters toxic impurities.
2. method according to claim 1, is characterized in that: described mobile phase is the mixed solvent gradient elution of organic phase and damping fluid, and during gradient elution 0 ~ 5min, the ratio of damping fluid, organic phase is volume ratio 90%:10%; During 5 ~ 14min, damping fluid volume ratio is reduced to 80%, and organic phase volume ratio increases to 20%; 14 ~ 15min, buffer ratio is that volume ratio is reduced to 10%, and the ratio of organic phase is that volume ratio increases to 90%; During 15 ~ 25min, the ratio of damping fluid, organic phase is that volume ratio 10%:90% is constant; During 25 ~ 30min, damping fluid volume ratio increases to 90%, and organic phase volume ratio is reduced to 10%; During 30 ~ 35min, the ratio of damping fluid, organic phase is that volume ratio 90%:10% is constant.
3. method according to claim 1 and 2, is characterized in that: described organic phase is acetonitrile.
4. method according to claim 1 and 2, is characterized in that: described damping fluid is for being selected from acetate buffer.
5. method according to claim 4, is characterized in that: the concentration range of described damping fluid is 0.005mol/L ~ 0.05mol/L, preferred 0.01mol/L.
6. method according to claim 4, is characterized in that: the pH value of described damping fluid is 3.0 ~ 5.1.
7. method according to claim 1, is characterized in that: the flow velocity of mobile phase is 1.0mL/min.
8. method according to claim 1, is characterized in that: column temperature is 25 DEG C.
9. method according to claim 1, is characterized in that: determined wavelength is 260nm.
CN201410215531.2A 2014-05-21 2014-05-21 A method of measuring sulfonic acid esters genotoxicity impurity using HPLC Active CN105092754B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410215531.2A CN105092754B (en) 2014-05-21 2014-05-21 A method of measuring sulfonic acid esters genotoxicity impurity using HPLC

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410215531.2A CN105092754B (en) 2014-05-21 2014-05-21 A method of measuring sulfonic acid esters genotoxicity impurity using HPLC

Publications (2)

Publication Number Publication Date
CN105092754A true CN105092754A (en) 2015-11-25
CN105092754B CN105092754B (en) 2018-09-18

Family

ID=54573661

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410215531.2A Active CN105092754B (en) 2014-05-21 2014-05-21 A method of measuring sulfonic acid esters genotoxicity impurity using HPLC

Country Status (1)

Country Link
CN (1) CN105092754B (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107014910A (en) * 2016-01-27 2017-08-04 重庆华邦制药有限公司 The separation of Apremilast and its latent gene toxic impurities and assay method
CN107014909A (en) * 2016-01-27 2017-08-04 重庆华邦制药有限公司 The separation of posaconazole intermediate Z and its genotoxicity impurity and assay method
CN107037153A (en) * 2017-04-21 2017-08-11 常州佳德医药科技有限公司 The method that high performance liquid chromatography detects genotoxicity impurity in AL58805 bulk drugs or pharmaceutical preparation
CN107677751A (en) * 2017-11-03 2018-02-09 江苏开元药业有限公司 A kind of method of high performance liquid chromatography detection Amlodipine Besylate Tablet and its impurity
CN107782820A (en) * 2016-08-31 2018-03-09 江苏正大丰海制药有限公司 The assay method of genetoxic impurity ethyl p-toluenesulfonate in a kind of brufen
CN108008024A (en) * 2017-08-31 2018-05-08 嘉实(湖南)医药科技有限公司 The detection method of genotoxicity impurity in doxofylline bulk pharmaceutical chemicals
CN109212068A (en) * 2018-09-21 2019-01-15 上海现代制药海门有限公司 A kind of efficient liquid phase detection method of the genotoxicity impurity of Zidovudine
CN110618219A (en) * 2019-09-25 2019-12-27 深圳海王医药科技研究院有限公司 Method for detecting residual solvent of trifluoromethanesulfonic acid
CN112203738A (en) * 2018-01-27 2021-01-08 耶拿弗里德里希·席勒大学 Method for determining impurities in polyalkylene ethers or polyalkylene amines and use thereof
CN111505163B (en) * 2020-05-18 2021-02-12 上海博悦生物科技有限公司 Method for detecting phenethyl methane sulfonate substances
CN114487141A (en) * 2020-10-28 2022-05-13 杭州中美华东制药有限公司 Method for detecting genotoxic impurities in indobufen bulk drug

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005017264A (en) * 2002-10-01 2005-01-20 Kazuhiro Imai Method of detecting/separating/identifying micro amount of expression protein/peptide, and system therefor
CN103728404A (en) * 2013-12-12 2014-04-16 浙江树人大学 Method for measuring content of methylmethanesulfonate (MMS) by utilizing ion chromatography and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005017264A (en) * 2002-10-01 2005-01-20 Kazuhiro Imai Method of detecting/separating/identifying micro amount of expression protein/peptide, and system therefor
CN103728404A (en) * 2013-12-12 2014-04-16 浙江树人大学 Method for measuring content of methylmethanesulfonate (MMS) by utilizing ion chromatography and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AMASA NAGESWARI ET AL: "A Sensitive and Simple HPLC-UV Method for Trace Level Quantification of Ethyl p-Toluenesulfonate and Methyl p-Toluenesulfonate,T wo Potential Genotoxins in Active Pharmaceutical Ingredients", 《SCI. PHARM.》 *
连小刚 等: "衍生气相色谱法测定甲磺酸伊马替尼中甲磺酸烷基酯类", 《中国医药科学》 *
龚心实 等: "LC-MS/MS法检测盐酸鲁拉西酮中磺酸酯基因毒杂质", 《药学与临床研究》 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107014910A (en) * 2016-01-27 2017-08-04 重庆华邦制药有限公司 The separation of Apremilast and its latent gene toxic impurities and assay method
CN107014909A (en) * 2016-01-27 2017-08-04 重庆华邦制药有限公司 The separation of posaconazole intermediate Z and its genotoxicity impurity and assay method
CN107014910B (en) * 2016-01-27 2021-03-12 重庆华邦制药有限公司 Separation and determination method of apremilast and potential genotoxic impurities thereof
CN107782820A (en) * 2016-08-31 2018-03-09 江苏正大丰海制药有限公司 The assay method of genetoxic impurity ethyl p-toluenesulfonate in a kind of brufen
CN107037153A (en) * 2017-04-21 2017-08-11 常州佳德医药科技有限公司 The method that high performance liquid chromatography detects genotoxicity impurity in AL58805 bulk drugs or pharmaceutical preparation
CN107037153B (en) * 2017-04-21 2019-05-14 常州佳德医药科技有限公司 The method that high performance liquid chromatography detects genotoxicity impurity in AL58805 bulk pharmaceutical chemicals or pharmaceutical preparation
CN108008024A (en) * 2017-08-31 2018-05-08 嘉实(湖南)医药科技有限公司 The detection method of genotoxicity impurity in doxofylline bulk pharmaceutical chemicals
CN107677751A (en) * 2017-11-03 2018-02-09 江苏开元药业有限公司 A kind of method of high performance liquid chromatography detection Amlodipine Besylate Tablet and its impurity
CN107677751B (en) * 2017-11-03 2021-04-20 江苏开元药业有限公司 Method for detecting amlodipine besylate and impurities thereof by high performance liquid chromatography
CN112203738A (en) * 2018-01-27 2021-01-08 耶拿弗里德里希·席勒大学 Method for determining impurities in polyalkylene ethers or polyalkylene amines and use thereof
CN109212068A (en) * 2018-09-21 2019-01-15 上海现代制药海门有限公司 A kind of efficient liquid phase detection method of the genotoxicity impurity of Zidovudine
CN110618219A (en) * 2019-09-25 2019-12-27 深圳海王医药科技研究院有限公司 Method for detecting residual solvent of trifluoromethanesulfonic acid
CN110618219B (en) * 2019-09-25 2022-08-19 深圳海王医药科技研究院有限公司 Method for detecting residual solvent of trifluoromethanesulfonic acid
CN111505163B (en) * 2020-05-18 2021-02-12 上海博悦生物科技有限公司 Method for detecting phenethyl methane sulfonate substances
CN114487141A (en) * 2020-10-28 2022-05-13 杭州中美华东制药有限公司 Method for detecting genotoxic impurities in indobufen bulk drug

Also Published As

Publication number Publication date
CN105092754B (en) 2018-09-18

Similar Documents

Publication Publication Date Title
CN105092754A (en) Method for determining sulfonate genotoxic impurity by using HPLC
CN104655751A (en) Method for detecting residual organic solvents in dapoxetine
CN105891351B (en) A kind of new Tauro ursodesoxy cholic acid content and the detection method in relation to substance
CN105717230A (en) Method for detecting residual organic solvent in Favipiravir
CN105067724A (en) Method for detecting organic solvent residue in Cetilistat
CN104237408B (en) The detection method of compound Chlorhexidine dyclonine emulsifiable paste
CN103743844B (en) The assay method of ethanol content in methyl alcohol
CN105092720A (en) Method for measuring genotoxic impurities in pradaxa
CN102841170A (en) Method for detecting impurity phenylhydrazine in edaravone
CN105929045A (en) Method for detecting residual organic solvent in cis-atracurium besilate
CN106198819B (en) The method of residual solvent in Headspace Gas Chromatography Xi Gelieting bulk pharmaceutical chemicals
CN105806968A (en) Gas chromatography method for simultaneously detecting n-heptane, isooctane, ethyl acetate and isopropanol and use thereof
CN106033079A (en) Method for detecting related substance imidazole in starting material F of dabigatran etexilate mesylate
CN104914178B (en) Method for determining fructose and glucose in honey through high performance liquid chromatography
CN103645259B (en) Method for simultaneously determining 4-amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione and related substances thereof
CN105572240A (en) Method for detecting content of pharmaceutic adjuvant carmine by using high performance liquid chromatography
CN102565208A (en) Novel method for detecting etimicin sulfate
CN105467028A (en) A method of separating and measuring optical isomers of a lurasidone intermediate by gas chromatography
CN108181386A (en) A kind of method in relation to substance in separation determination Abiraterone acetate intermediate
CN101458235A (en) Matrine liquid chromatography measuring method
CN104062390B (en) The detection method of chloroform, carbon tetrachloride in chlorinated polypropylene
CN105277633B (en) A kind of defects inspecting analysis method of norethindrone derivative and its intermediate
CN107703225A (en) A kind of detection method for determining organic solvent residual in bromhexine hydrochloride raw material
CN105954431B (en) A kind of method of the HPLC separation determination Ao Pei meter Fen bulk pharmaceutical chemicals in relation to substance
CN105158348A (en) Method for determining five effective components in zedoary oil by using gas chromatography

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant